Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Numares AG. (7/6/16). "Press Release: Laboratory Group Limbach Expands Lipid Analysis with Numares Test". Regensburg.

Organisations Organisation Numares AG
  Group Numares (Group)
  Organisation 2 Labor Limbach (Group)
  Today MVZ Labor Dr. Limbach & Kollegen GbR (Labor Limbach Heidelberg)
Products Product diagnostic test
  Product 2 diagnostic services
Person Person Pfahlert, Volker (LipoFIT GmbH 201001– Managing Director COO before Roche Diagnostics + Dräger Medical)

The Laboratory Group Limbach is using the in vitro diagnostic (IVD) test LipoComplete from numares. Meaning Limbach’s lipid analysis service portfolio now includes a mass-market blood test for determining individual lipoprotein profiles. In addition to the standard lipid metabolism parameters (triglycerides, total cholesterol, LDL cholesterol, HDL cholesterol), LipoComplete provides further information on the particle properties (concentration, mean diameter) of various lipoprotein subclasses, such as the highly atherogenic small dense LDL (sdLDL). The new test is designed to allow a more differentiated risk assessment of cardiovascular diseases.

By adding the LipoComplete test to its service portfolio, Limbach has expanded its lipoprotein diagnostics to include a modern and high-throughput routine analysis. The test is based on the CE-marked IVD test lipoFIT-S100, which numares launched in 2015. It allows 29 lipoprotein parameters such as particle concentration and diameter to be determined as well as the lipid concentration of lipoprotein particles such as triglycerides and cholesterol. Limbach wants to establish the new test as part of routine diagnostics and use it for things such as risk stratification and treatment monitoring during statin therapy. However, LipoDens® will continue to be the reference method of lipoprotein analytics, especially for the examination of problematic samples.

Limbach is already offering the product LipoDens® for advanced lipoprotein diagnostics. The analysis of lipoprotein subclasses with LipoDens® is performed by way of ultracentrifugation, a precise method that can be used for problematic sera in particular. However, particle properties such as concentration and the average diameter of lipoprotein particles cannot be determined with the LipoDens® method. Ultracentrifugation is also a very complicated method with limited sample throughput.

"Our goal is to offer a differentiated analysis for each patient. And we now have the right procedure to do so thanks to the high-throughput solution from numares. We can now supply the parameters most important for physicians’ diagnosis and therapy - accurately and in the shortest possible time”, says Dr. Dietmar Plonné, dyslipidemia expert at the Limbach laboratory group.

”Until now, lipoprotein analyses were limited to 16 tests per day using the gold standard LipoDens® and as such were not suitable for high demand“, adds Dr. Volker Pfahlert, chairman of the Executive Board at numares AG. ”With LipoComplete, Limbach has expanded its test portfolio to include an analysis method that enables a throughput of more than 250 samples per day.”

LipoComplete is now available to any patient in Germany. The blood test can be requested via your family doctor and ordered at the MVZ Laboratory Ravensburg of Limbach Group.


The measurement of lipids in the blood is an integral part of today’s diagnostic routine.

As part of basic diagnostic screening for widespread dyslipidemia and CHD risk stratification, triglycerides, total cholesterol, LDL1 cholesterol and HDL2 cholesterol are determined in serum as standard. These are of a varying composition, packed in so-called lipoprotein classes that are divided into further subclasses according to size, density and particle concentrations, and that differ in their atherogenic effect. A growing number of scientific publications and guidelines show that considering lipoprotein subclasses and particle concentrations such as LDL-P can contribute to a better risk stratification and prediction of cardiovascular events.

1LDL = low density lipoprotein, 2HDL = high density lipoprotein

About Limbach

The Medical Care Center Ravensburg - also known as Dr. Gärtner laboratory - belongs to the Limbach Group and stands for quality-conscious medical laboratory diagnostics in Germany. With a total of 30 individual laboratories under medical direction, the newly created Limbach Group is a reliable partner for physicians, hospitals and other medical facilities. The diagnostics services offered throughout Germany include both basic diagnostics and special analytics as well as medical advice for all clinical disciplines.

Contact details Limbach

PD Dr. med. Dietmar Plonné
Facharzt für Laboratoriumsmedizin
Tel.: +49 731-85070540
Fax: +49 731-85070568
E-Mail: d.plonne(at)

Media contact

numares AG
Dipl.-Biol. Christiane Proll, MBA
Tel.: +49 941 2809 49-14
E-Mail: christiane.proll(at)

Dr. Reinhard Saller
Tel.: +49 89 2000 30-38
E-Mail: reinhard.saller(at)

Record changed: 2017-01-05


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Numares (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

» top